You are here
Do you have any suggestions on SMEs that are currently preparing for the preclinical phase?
Should we apply to the classic SME Instrument measures and THEN apply for a clinical trial program like the PM-11? (I'm asking this because it isn't clear whether the Horizon 2020 programmes support preclinical studies.)
HORIZON 2020 also supports preclinical activities. The scope section of each topic clearly describes the expected activities. In order to clarify content-related questions please seek advice e.g. from your National Contact Point.